DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay

The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.

Related Keywords

Italy ,Saluggia ,Piemonte ,Diasorin Luminex ,Angelo Rago ,Human Service Biomedical Advanced Research ,Us Department Of Health ,Drug Administration ,Development Authority ,California Based Diasorin Molecular ,Use Authorization ,Simplexa Flu ,